[1] PATEL S G, KARLITZ J J, YEN T, et al. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection[J]. Lancet Gastroenterol Hepatol, 2022, 7(3):262-274. [2] KAMARADOVA K. Non-conventional types of dysplastic changes in gastrointestinal tract mucosa - review of morphological features of individual subtypes[J]. Cesk Patol, 2022, 58(1):38-51. [3] KEUM N, GIOVANNUCCI E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(12):713-732. [4] DEKKER E, TANIS P J, VLEUGELS J, et al. Colorectal cancer[J]. Lancet, 2019, 394(10207):1467-1480. [5] CROSS A J, ROBBINS E C, PACK K, et al. Post-polypectomy surveillance interval and advanced neoplasia detection rates: a multicenter, retrospective cohort study[J]. Endoscopy, 2022, 54(10):948-958. [6] SHEN X, WANG Y, ZHAO R, et al. Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis[J]. Int J Colorectal Dis, 2021, 36(10):2215-2225. [7] SULLIVAN B A, NOUJAIM M, ROPER J. Cause, epidemiology, and histology of polyps and pathways to colorectal cancer[J]. Gastrointest Endosc Clin N Am, 2022, 32(2):177-194. [8] CHEN D, ZHOU X, YAN P, et al. Lipid metabolism reprogramming in colorectal cancer[J]. J Cell Biochem, 2023, 124(1):3-16. [9] XU W, HE Y, WANG Y, et al. Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies[J]. BMC Med, 2020, 18(1):172. [10] BRIGGS S, LAW P, EAST J E, et al. Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study[J]. BMJ, 2022, 379:e71707. [11] RYOO S K, KIM T J, KIM E R, et al. Helicobacter pylori infection and the development of advanced colorectal neoplasia[J]. J Clin Gastroenterol, 2020, 54(8):696-700. |